Xos Amends Convertible Note, Drastically Cuts Conversion Price to $12.00, Increasing Dilution Risk
XOS sits 23% above its 52-week low of $1.6 on elevated volume (2.7× avg).
Summary
Xos, Inc. finalized an amendment to a $15.5 million convertible note, slashing the conversion price from $71.45 to $12.00 per share, which could lead to significant dilution if approved by shareholders.
Key Events · Financing and Capital Events · XOS
-
Convertible Note Terms Finalized
The company amended its convertible promissory note with Aljomaih Automotive Co., reducing the conversion price from $71.451 to $12.00 per share for the $15.5 million outstanding principal.
-
Significant Potential Dilution
This amendment makes 1,291,666 shares convertible, representing a substantial potential increase in outstanding shares, which shareholders are being asked to approve as part of Proposal 6.
-
Increased Investor Stake
Aljomaih Automotive Co. now beneficially owns approximately 28.0% of the company's common stock, including these convertible shares.
-
Mandatory Conversion Feature Added
A new clause allows Xos to compel conversion if the stock's VWAP exceeds $16.00 for at least 20 out of 30 trading days.
Analysis · XOS · Manufacturing
Xos, Inc. has finalized the terms of a critical convertible note amendment with Aljomaih Automotive Co., which shareholders are asked to approve. The conversion price for the $15.5 million outstanding principal has been drastically reduced from $71.45 to $12.00 per share. This significant reduction makes conversion much more likely, potentially adding 1.29 million shares to the outstanding count, representing substantial dilution for existing shareholders. This move, coupled with a new mandatory conversion feature, indicates the company is making significant concessions to secure financing amidst its ongoing "going concern" warning and previous dilutive activities.
At the time of this filing, XOS was trading at $1.97 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $24.3M. The 52-week trading range was $1.60 to $5.60. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.